Jonathan Symonds

Jonathan Symonds is a declared insider at 2 companies; the most frequent names are Innocoll Holdings plc and Rubius Therapeutics, Inc. In total, 2 filings cover trades dated from 24 July 2017 to 20 July 2018.

On the market, this insider has only ever bought: 1 purchase, €493k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2018, the count stands at 1 purchase and no sales.

On 23 July 2018 came the latest disclosure, an open-market purchase for €493k in Rubius Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.